Prelude Capital Management, LLC Eton Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.71 - $8.85 $176,467 - $273,509	-30,905 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.93 - $10.07 $7,318 - $10,633	-1,056 Reduced 3.3%	30,905 $226,000
Q4 2020 Feb 16, 2021	BUY	$6.65 - $8.83 $74,140 - $98,445	11,149 Added 53.57%	31,961 $260,000
Q3 2020 Nov 16, 2020	SELL	$4.96 - $9.06 $671,405 - $1.23 Million	-135,364 Reduced 86.67%	20,812 $164,000
Q2 2020 Aug 14, 2020	SELL	$3.5 - $6.09 $425,323 - $740,062	-121,521 Reduced 43.76%	156,176 $851,000
Q1 2020 May 15, 2020	BUY	$2.87 - $7.47 $429,733 - $1.12 Million	149,733 Added 117.01%	277,697 $1.14 Million
Q4 2019 Feb 14, 2020	BUY	$5.59 - $7.2 $301,988 - $388,965	54,023 Added 73.06%	127,964 $921,000
Q3 2019 Nov 14, 2019	BUY	$5.19 - $8.72 $93,663 - $157,369	18,047 Added 32.29%	73,941 $467,000
Q2 2019 Aug 14, 2019	BUY	$7.1 - $8.39 $135,411 - $160,014	19,072 Added 51.8%	55,894 $442,000
Q1 2019 May 15, 2019	BUY	$5.72 - $8.0 $66,077 - $92,416	11,552 Added 45.71%	36,822 $295,000
Q4 2018 Feb 14, 2019	BUY	$5.79 - $6.68 $146,313 - $168,803	25,270 New	25,270 $155,000

9.44M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $264M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.